Everotas 0.25mg Tablet: Effective Relief for Your Needs

Everotas 0.25mg Tablet

Uses:

• Advanced breast cancer
• Advanced renal cell carcinoma
• Advanced pancreatic neuroendocrine tumours
• Treatment of subependymal giant cell astrocytoma

Therapeutic Effects:

• Inhibits the activity of mammalian target of rapamycin (mTOR), a protein that regulates cell growth
• Slows the growth of abnormal cancer cells
• Reduces the size of tumours
• Improves outcomes in patients

Interaction with other drugs:

• Inform your healthcare provider about all the medicines you take
• Certain medications may interact with Everotas 0.25mg tablet and reduce effectiveness

Safety Advices:

• Not recommended for pregnant women as it may cause fetal harm
• Unsafe to consume while breastfeeding
• Consult your doctor if you have any lung diseases before starting the treatment
• Inform your doctor if you have any liver problems
• Stop consuming alcohol if you are taking this medicine
• Unsafe to drive vehicles or operate heavy machinery after taking Everotas 0.25mg tablet

Storage:

• Store Everotas 0.25mg tablet in the original package at room temperature (20°C to 25°C)
• Keep it out of reach from children

How to consume:

• Take the Everotas 0.25mg tablet as advised by your physician
• Do not crush, chew, or open the medicine
• Your physician will decide the correct dosage and duration based on age, body weight, and disease condition
• Only stop taking the tablet if your doctor advises you to stop

Side Effects:

• Difficulty breathing or swallowing
• Swelling of face, lips, tongue, throat
• Severe itching, red rash, raised bumps
• Infection (chills, increased temperature)
• Coughing
• Wheezing
• Excessive thirst
• High urine output or severely decreased urine output
• Tiredness
• Bleeding
• Increased appetite with weight loss

Word of Advice:

• Inform your healthcare provider before starting this treatment if you are pregnant or planning for pregnancy
• Discuss effective birth control methods with your healthcare provider and use them during the treatment for 8 weeks after your last dose
• The occurrence of mouth ulcers or sores is common during this treatment, so your healthcare provider will prescribe a mouthwash

FAQs:

1. What you should know before taking Everotas 0.25mg tablet?

• Your risk of getting bacterial or viral infection increases with this treatment
• If you have been infected with Hepatitis B, this drug increases the chances of reinfection
• Tell your healthcare provider if you experience fever, chills, cough, yellowing of the skin, joint pain, or swelling during this treatment

2. Is it safe to use Everotas 0.25mg tablet during pregnancy?

• Everotas 0.25mg tablet have the tendency to cause harm to the unborn fetus
• Inform your healthcare provider before starting this treatment if you are pregnant or planning for pregnancy

3. What are the side effects of Everotas 0.25mg Tablet?

• Fever, chills, skin rash, joint pain, swelling, tiredness, loss of appetite, high risk of infection, mouth ulcers, and difficulty breathing

4. Is it safe to undergo surgery while on treatment with Everotas 0.25mg tablet?

• Everotas 0.25mg tablet may lead to poor wound healing ability
• Consult your healthcare provider and stop taking this tablet at least one week before planned surgery

5. Can I drink alcohol while taking Everotas 0.25mg tablet?

• It is generally recommended to avoid drinking alcohol while taking Everotas 0.25mg tablet, as alcohol can increase the risk of liver damage

Fact Box:

• Molecule name: Everolimus
• Therapeutic class: Antineoplastics
• Pharmacological class: mTOR kinase inhibitors

Tags: Everotas, tablet, medication, 0.25mg, health, drug, pharmaceutical, medical-treatment, pills